OSCC local drug delivery review: matching formulation to tumour
A new international review suggests that local drug delivery systems for oral squamous cell carcinoma must be tailored to specific tumor characteristics rather than using a one-size-fits-all formulation. Researchers emphasize that the dynamic environment of the mouth requires clinical context to ensure treatment efficacy.
Why it matters
Improving localized drug delivery can increase cancer treatment success rates while minimizing systemic side effects for patients.
A new review is highlighting a key challenge in the development of local drug-delivery systems for oral squamous cell carcinoma (OSCC): there may be no single formulation that works equally well for every tumour.
The review, conducted by researchers from Indonesia, Japan and China, examines emerging approaches designed to deliver drugs directly to oral tumours. These include mucoadhesive films and patches, oral sprays, in-situ gels and injectable hydrogels.
Rather than treating drug delivery as primarily a formulation problem, the researchers argue that development should begin with the clinical characteristics of the tumour, the drug being delivered and the conditions within the mouth.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in